期刊文献+

原发性胆汁性肝硬化患者生化及免疫学检测指标的观察 被引量:1

下载PDF
导出
摘要 原发性胆汁性肝硬化(primary biliary cirrhosis,PBC)是一种原因不明的慢性进行性胆汁淤积性肝脏疾病,多见于中老年女性。其特征为肝内胆小管非化脓性进行性破坏伴门静脉炎症改变,并长期持续性胆汁淤积,最终导致肝纤维化及肝硬化。该病是典型的自身免疫性肝病之一,目前尚无特异的诊断方法。一般认为抗线粒体抗体(AMA)及其亚型AMA—M2对PBC检测虽具有一定的特异性,但还存在着一定比例的阴性患者,故需结合其他的实验室指标作进一步分析。本文分析了41例PBC患者和38例乙型肝炎肝硬化患者的生化和免疫学指标,旨在探讨早期诊断PBC的方法。
作者 金文君
机构地区 湖州市中心医院
出处 《浙江医学》 CAS 2008年第1期84-85,共2页 Zhejiang Medical Journal
  • 相关文献

参考文献10

  • 1闫惠平,庄辉,刘燕敏,冯霞,檀玉芬,刘妍,张欣,赵春惠.原发性胆汁性肝硬化患者的免疫学特点分析[J].中华肝脏病杂志,2005,13(1):12-16. 被引量:49
  • 2Margaret F B, David E J J. Antimitochondrial and other autoantibodies in primary biliary cirrhosis [M]//Autoimmune liver disease, 2nd ed. Amsterdam:Elsevier, 1998:287-304.
  • 3Talwalkar J A, Lindor K D.Primary biliary cirrhosis [J]. Lancet, 2003, 362:53-61.
  • 4Metcalf J V, Mitchison H C, Palmer J M, et al. Natural history of early primary biliary cirrhosis[J]. Lancet, 1996, 348:1399-1402.
  • 5Kisand K E, Metskula K, Kisand K V, et al. The follow-up of asym tom atic persons with antibodies to pyruvate dehydrogenase in adult population samples[J]. J Gastroenterol, 2001,36:248-254.
  • 6Clauda J C, Howard J W, Nuclear envelope pootein autoantibodies in primary diliary cirrhosis[J]. Semin Liver Dis,1997, 17:79- 80.
  • 7Mickay I R, whittingham S, Fida S, et al. The peculiar ruto immunity of primary biliary cirrhosis [J]. Immunol Rer 2000,174:226- 237.
  • 8张福奎.原发性胆汁性肝硬化的实验诊断进展[J].国外医学(临床生物化学与检验学分册),2002,23(2):118-119. 被引量:6
  • 9姚定康,谢渭芬,汪磊.22例原发性胆汁性肝硬化的临床分析[J].中华肝脏病杂志,2002,10(5):344-346. 被引量:12
  • 10Lacerda M A, Ludwing J, Dickson E R, et al. Antimito chndrial antiboay negative primary biliary cirrhosis [J].Am J Gastroenterol, 1995, 90:247-249.

二级参考文献29

  • 1Leuschner U. Primary biliary cirrhosis-presentation and diagnosis.Clin Liver Dis, 2003, 7: 741-758.
  • 2Pares A, Rodes J Natural history of primary biliary cirrhosis. Clin Liver Dis, 2003, 7: 779-794.
  • 3Leung PS, Coppel RL, Gershwin ME. Mitochondrial antibodies. In:Peter JB ,Shoenfeld Y, Editors. Autoantibodies. Amsterdam: Elsevier Science B V 1996. 494-500.
  • 4Leung PS, Van de Water J, Coppel RL, et al. Molecular aspects and the pathological basis of primary biliary cirrhosis. J Autoimmun,1996, 9: 119-128.
  • 5Metcalf JV, Mitchison HC, Palmer JM, et al. Natural history of early primary biliary cirrhosis. Lancet, 1996, 348: 1399-1402.
  • 6Zhang F, Jia J, Cui R, et al. Clinical features of forty patients with primary biliary cirrhosis. Chin Med J (Engl), 2002, 115: 904-908.
  • 7Berg PA, Klein R. Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance. Dig Dis, 1992, 10: 85-101.
  • 8lein R, Pointner H, Zilly W, et al. Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years. Liver, 1997, 17:119-128.
  • 9Wichmann I, Montes-Cano MA, Respaldiza N, et al. Clinical significance of anti-multiple nuclear dots/Sp100 autoantibodies. Scand J Gastroenterol, 2003, 38: 996-999.
  • 10Lohse AW. Overlap syndromes exist. Gastroenterology Week, October 12-17, 2004, Freiburg, Germany.

共引文献62

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部